Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| AvevoRx Announces National Director of Pharmacy Operations Named to Triad Business Journal's "40 Leaders Under 40" | ||
| By: PR Newswire Association LLC. - 22 Feb 2024 | Back to overview list |
|
|
Justin R. Dent, PharmD, recognized for his leadership in expanding specialty infusion pharmacy services and ensuring personalized care for patients with chronic, complex conditions GREENSBORO, N.C., Feb. 22, 2024 /PRNewswire-PRWeb/ -- AvevoRx, an independent provider of specialty infusion pharmacy services, is proud to announce its National Director of Pharmacy Operations, Justin R. Dent, PharmD, has been named to the Triad Business Journal's prestigious "40 Leaders Under 40" list. The 2024 list spotlights extraordinary young leaders with significant career achievements who work and are civically engaged in the Triad community of North Carolina. "I've been described as a careful risk-taker, which is fitting. If I didn't embrace the occasional risk, I would not have found success professionally or personally." As its National Director of Pharmacy Operations, Dent ensures the smooth and efficient day-to-day operations of AvevoRx's pharmacy services at scale. He oversees the company's clinical services, including three specialty infusion pharmacy distribution centers, four ambulatory infusion suites, and the in-home administration of complex intravenous drugs to thousands of patients. He currently leads over 160 employees and is responsible for $90 million in revenue. Dent's most significant achievements include helping to expand the company's national footprint and experience with pharmacy law and accreditation compliance. He holds RPH licensure in 14 states and is experienced in ACHC and URAC accreditation requirements. He has demonstrated command of the assessment and implementation of myriad IT systems and is passionate about those that improve processes, productivity, and quality. Dent has managed three new pharmacy facility startups from the ground up, including USP 797-compliant cleanrooms. Dent has demonstrated exceptional leadership throughout his career, beginning as a retail pharmacist before transitioning into the uniquely challenging specialty pharmacy and infusion industry. At just 26, he led the launch of a $30 million pharmacy distribution center. With AvevoRx, he's led two acquisitions and the opening of a start-up location in Greensboro. He's scaled the company to a run rate of $90 million in under two years while onboarding over 100 employees and clinicians. He has implemented several significant systems and regulatory upgrades and managed annual growth rates of >350 percent. Dent is considered AvevoRx's first employee and is valued as a top executive by C-suite leadership, several of whom he has worked with elsewhere over the last decade. When asked how he achieves success as a leader, Dent describes himself as the "all-in" type. "I've been described as a careful risk-taker, which is fitting. If I didn't embrace the occasional risk, I would not have found success professionally or personally," he continued. Dent holds a B.A. in Chemistry with a minor in Biological Sciences from North Carolina State University. He earned his PharmD (Doctor of Pharmacy) from the University of North Carolina at Chapel Hill. He is a native of Bluefield, West Virginia, and was raised in Welch, West Virginia, until he moved to the greater Triad area at age 12. Dent lives in High Point with his wife and two children. He is an active civil volunteer and considers his healthcare mission to Haiti with fellow pharmacy and medical professionals a personal and professional highlight. He has been with AvevoRx for nearly three years and looks forward to seeing the company's continued growth. "In the past few years, we have expanded our services to cover patients in more than half the country," Dent says. "Our founders established a solid base, and we're constantly enhancing our operations to provide specialty pharmacy care to as many patients as possible. I am excited to see how my role in operations evolves as those enhancements play out." AvevoRx has experienced rapid growth over the past year, expanding its licensure to 30 states nationwide, delivering expert infusion care for patients with chronic, complex conditions in the comfort of their homes. AvevoRx specializes in immune globulin (IG), Alpha-1 proteinase inhibitors, bleeding disorder management, and monoclonal antibody treatments. Learn more by visiting www.AvevoRx.com. Read more about Justin and the 40 Leaders Under 40 by visiting the Triad Business Journal online. About AvevoRx AvevoRx is a bespoke, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients with complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies on a regional basis for patients with short-term therapeutic needs. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit www.AvevoRx.com or follow us on Instagram or LinkedIn. Media Contact
SOURCE AvevoRx 
|
||
|
|
||
 | Back to overview list | |
View original content to download multimedia: